Board of Directors

Board of Directors

Tony Di Benedetto Executive Chairman

Tony Di Benedetto is a Canadian technology entrepreneur with over 30 years of hands-on experience in building, operating, and divesting technology companies. Most recently, Mr. Di Benedetto was the co-founder of Drone Delivery Canada (TSXV:FLT), which he took public and successfully raised over $120M in equity financing, achieving market capitalization in excess of $550M. Mr. Di Benedetto has also co-founded several technology companies including Data Centers Canada – a colocation data center facility in Vaughan, Ontario – which he later sold to Terago Networks (TSX:TGO). Other technology enterprises Di Benedetto developed include system integration/managed services businesses, hosting, and one of southern Ontario’s largest fixed wireless broadband networks, all of which he successfully divested. Mr. Di Benedetto holds a degree from York University.

Richard Buzbuzian President, Director

Richard Buzbuzian is a capital markets executive with over 25 years of investment experience in Canada and Europe. Most recently, Mr. Buzbuzian was president and a director of Drone Delivery Canada (TSXV: FLT), which he cofounded, took public, and raised over $120M Canadian in equity financings, achieving market capitalization in excess of $550M. Mr. Buzbuzian holds a degree from the University of Toronto.

Dr. John Leombruno Director

John Lemobruno has executive level experience in many areas of the pharmaceutical industry, including market access, medical information, pharmacovigilance, medical affairs, and business development. He co-founded Patient Direct (a patient support and specialty pharmacy provider) and GMD Distribution (a pharmaceutical distribution, patient support and specialty pharmacy services firm), both of which were acquired by McKesson Canada between 2010 and 2017. In 2019, John started OkRx, a Canadian Healthcare software company focusing on helping patients, prescribers, insurers, and pharmaceutical companies manage specialty medications. Dr. Leombruno is formally trained as a Pharmacist and has earned an MBA from Queen’s University and a PhD in Pharmacoepidemiology from University of Toronto.

Karen Dunlap Director

Karen Dunlap was President/COO, The Americas, UK, Europe and Board Director at Sol-Millennium Medical Group, from September 2011 – December 2019, responsible for acquisition of devices in order to launch into the US and overseeing markets to develop a strategic platform and establish a global sales/marketing team. She was a Sr. Vice President Business Development from March 2005 - September 2011 for Inviro Medical, and represented the company in many different roles and regions including Target Accounts US, Canada and Latin America. Prior to working with Inviro Medical, Ms. Dunlap was an independent consultant working with start-up emerging companies on product development and launch. Ms. Dunlap was Vice President Sales for NMT, partnering with Pharmaceutical Companies on specific medication delivery, and Regional Manager for Medfusion and Medex, focused in the Neonatal and Pediatric markets, where she has extensive experience in accurate medication delivery systems.

Philip Cortese Director

Mr. Cortese is a seasoned banker with over 30 years of experience in the financial institution industry and has held senior managerial positions at RBC, TD Bank and CIBC for over half of those years. In 2002, he was recruited by TD Bank to head the Quebec office of its real estate financing commercial mortgage-backed securities (CMBS) origination group as vice-president for the Quebec region. The CMBS group originated close to $1 billion of new commercial mortgages over a period of just 4 years. In October of 2012, he joined a local real estate investor, Kheng Ly, and together branded the development company now known as Brivia Group. Mr. Cortese is a former Canadian Securities Institute graduate and a licensed commercial real estate broker.

Chris Irwin Director

Chris practices securities and corporate/commercial law and has been the president of Irwin Professional Corporation since August 2006. He advises several public companies on a variety of issues including continuous disclosure and regulatory issues, reverse-takeover transactions, initial public offerings, and takeover bids. Mr. Irwin also advises boards of directors, including independent committees. Mr. Irwin is a director and/or officer of several public companies including Seafield Resources Ltd., Laramide Resources Ltd., Roscan Minerals Corporation, Canada Lithium Corp., Trelawney Mining and Exploration Inc., and Ursa Major Minerals Incorporated. Mr. Irwin has served as a member of the independent committees for both Trelawney Mining and Exploration Inc. and Seafield Resources Ltd.

Subscribe to News